Resource data sheet
Prev.
Please review the QC test results indicated by check icon below as well as clone information before placing your order.

mitoKeima-Red

Expression vector encoding mitochondrially targeted Keima-Red (mitoKeima-Red).

Catalog number RDB18369
Resource name mitoKeima-Red
Clone info. Expression vector encoding mitochondrially targeted Keima-Red (mitoKeima-Red). The mitochondria-targeting amino acid sequence MLSLRQSIRFFKPATRTLCSSR, derived from cytochrome oxidase subunit IV.
Comment Expression was confirmed by the depositor with fluorescence live cell imaging.
Vector backbone pcDNA3.1(+) (plasmid)
Size of vector backbone 5.4 kb
Selectable markers Ampicillin (E. coli), Neomycin (mammalian cells).
Gene/insert name Montipora sp. red fluorescent protein cDNA
Depositor|Developer Aoki, Shigeki |
Other clones in our bank

External Database
Montipora sp. red fluorescent protein

            Reference sequence
              
             
            Sequence (full) RDB18369zzk01.seq provided by the depositor

            Distribution information

            Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
            Terms and conditions for distribution In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of literature designated by the DEPOSITOR is requested. (Shiratori, R. et al. Sci. Rep.10; 9(1): 18699, 2019)
            Additional terms and conditions:
            A RECIPIENT who belongs to a non-profit organization may use the BIOLOGICAL RESOURCE for an academic research that is non-commercial. The RECIPIENT who belongs to commercial organization should obtain written approval from the Medical & Biological Laboratories Co., Ltd prior to MTA.
            Ordering Please visit Information of Request for Distribution.[link] 
            Order form 
            [Credit Card Payment]  [Bank Transfer Payment]
            Material Transfer Agreement (MTA for use for not-for-profit academic purpose) [Word]
            提供案内 (日本国内) [open/close]

            提供条件 利用者は、研究成果の公表にあたって寄託者の指定する文献を引用する(Shiratori, R. et al. Sci. Rep.10; 9(1): 18699, 2019)。
            付加的提供条件:
            非営利機関での学術研究目的での利用に限る。営利機関の利用者もしくは商業利用の場合はMBL社から事前にその旨の提供承諾を取得する。
            提供依頼 手続きの詳細は、「提供申込みについて[link]」をご覧ください。
            提供依頼書 [Word]
            提供同意書 (MTA、非営利機関による非営利学術研究用)[Word]

            Catalog # Resource name Shipping form Fee (non-profit org.)
            RDB18369 mitoKeima-Red DNA solution

            Please review the QC test results indicated by check icon below as well as clone information before placing your order.

            References and tips

            Original reference

            original Shiratori, R., Glycolytic suppression dramatically changes the intracellular metabolic profile of multiple cancer cell lines in a mitochondrial metabolism-dependent manner. Sci. Rep. 9 (1): 18699 (2019). PMID 31822748.

            Further references such as user reports and related articles (go to bottom)

            Featured content

            Featured content Mitophagy (English text)

            QC test results

            RIKEN BRC has sequenced portions of this material for quality test.
            Please review the QC test results indicated by check icon as well as clone information before placing your order.

            Test sheet RDB18369_B0Gmp1-1.pdf check

            Nucleotide sequence of a portion of this resource (if available).

            Primer: CMV_Forward (Pr0016)
            Region: CMV pro, mitoKeima-Red 5'
            Sequence file: RDB18369_B0Gma.seq check
            >D07172A1_B0Gm_3_CMV_Forward_G01_07_ABI08.ab1
                1 NNNNNNNNNN NNNNNNNNTG NNGCNNTGGG CGGTAGGCGT GTNCGGTGGG AGGTCTATAT
               61 AAGCAGAGCT CTCTGGCTAA CTAGAGAACC CACTGCTTAC TGGCTTATCG AAATTAATAC
              121 GACTCACTAT AGGGAGACCC AAGCTGGCTA GTTAAGCTTG CCATGCTGAG CCTGCGCCAG
              181 AGTATCCGCT TCTTCAAGCC CGCCACCAGG ACTCTGTGCA GTTCCAGGAT GGTGAGCGTG
              241 ATCGCCAAGC AGATGACCTA CAAGGTGTAC ATGAGCGGCA CCGTGAACGG CCACTACTTC
              301 GAGGTGGAGG GCGACGGCAA GGGCAAGCCC TACGAGGGCG AGCAGACCGT GAAGCTGACC
              361 GTGACCAAGG GTGGCCCCCT GCCCTTCGCC TGGGACATCC TGAGCCCCCA GCTCCAGTAC
              421 GGCAGCATCC CCTTCACCAA GTACCCCGAG GACATCCCCG ACTACTTCAA GCAGAGCTTC
              481 CCCGAGGGCT ACACCTGGGA GCGCAGCATG AACTTCGAGG ACGGCGCCGT GTGCACCGTG
              541 AGCAACGACA GCAGCATCCA GGGCAACTGC TTCATCTACA ACGTGAAGAT CAGCGGCGAG
              601 AACTTCCCCC CCAACGGCCC CGTGATGCAG AAGAAGACCC AGGGCTGGGA GCCCAGCACC
              661 GAGCGCCTGT TCGCCCGCGA CGGAATGCTG ATCGGCAACG ACTACANNNN NNTGAAGCTG
              721 GAGGGCGGCG GCCACTACCT GTGCGAGTTC AAGAGCACCT ACAANGCCAA GAAGCCCGTG
              781 ANGATGCCCG GCCGCCACGA NATCGANCGC AAGCTGGACG TGACCAGCCA CAACCGCGAC
              841 TACACCAGCG TGGANCAGTG CGANATCGCC ATCGCCCGCC NCANCCTGCT GGGCTNATCT
              901 AGANGGCCNG NNNNTCNAAN GNAAGCCTAT CCCTAACCNT NNNNNCGNNC TCNANTCNAC
            961 GCNNANNGGN CATCNTCNNN NTCNNNNNTN NANNTNNANN CNNNNNNNNN N
            //
            Primer: BGH_rev2 (Pr0606)
            Region: bGH pA, mitoKeima-Red 3'
            Sequence file: RDB18369_B0Gmb.seq check
            >D07172A1_B0Gm_3_BGH_rev2_H01_08_ABI08.ab1
                1 NNNNNNNNNN NNNNNNNNGG NNGNNGGGCA NCAACAGATG GCTGGCAACT AGAAGGCACA
               61 GTCGAGGCTG ATCAGCGGGT TTAAACTCAA TGGTGATGGT GATGATGACC GGTACGCGTA
              121 GAATCGAGAC CGAGGAGAGG GTTAGGGATA GGCTTACCTT CGAACCGCGG GCCCTCTAGA
              181 TTAGCCCAGC AGGCTGTGGC GGGCGATGGC GATCTCGCAC TGCTCCACGC TGGTGTAGTC
              241 GCGGTTGTGG CTGGTCACGT CCAGCTTGCG GTCGATCTCG TGGCGGCCGG GCATCCTCAC
              301 GGGCTTCTTG GCCTTGTAGG TGCTCTTGAA CTCGCACAGG TAGTGGCCGC CGCCCTCCAG
              361 CTTCAGGGCC ATGTAGTCGT TGCCGATCAG CATTCCGTCG CGGGCGAACA GGCGCTCGGT
              421 GCTGGGCTCC CAGCCCTGGG TCTTCTTCTG CATCACGGGG CCGTTGGGGG GGAAGTTCTC
              481 GCCGCTGATC TTCACGTTGT AGATGAAGCA GTTGCCCTGG ATGCTGCTGT CGTTGCTCAC
              541 GGTGCACACG GCGCCGTCCT CGAAGTTCAT GCTGCGCTCC CAGGTGTAGC CCTCGGGGAA
              601 GCTCTGCTTG AAGTAGTCGG GGATGTCCTC GGGGTACTTG GTGAAGGGGA TGCTGCCGTA
              661 CTGGAGCTGG GGGCTCAGGA TGTCCCAGGC GAAGGGCAGG GGGCCACCCT TGGTCACGGT
              721 CAGCTTCACG GTCTGCTCGC CCTCGTANGG CTTGCCCTTG CCGTCGCCCT CCACCTCGAA
              781 GTAGTGNNCG TTCACGGTGC CGCTCATGTA CACCTTGTAN GTCATCTGCT TGGCGATCAC
              841 GCTCACCATC CTGNAANTGC ACAGANNCCT GGTGNCGGGC TNGAAGAANC GGATACTCNG
              901 GNGCAGGNTC ANCATGGNNA GCNNAACNNN CCAGCTTGGG NCTCCNNATA NNGANTCNNA
            961 NTAATTTCNA NNNNCNANTN ANCNNNNNNN NNN
            //
            Primer: SV40pro_ori_F (Pr0731)
            Region: SV40 pro_ori, NeoR
            Sequence file: RDB18369_B0Gmc.seq check
            >D07172A1_B0Gm_3_SV40pro_ori_F_G04_07_ABI08.ab1
                1 NNNNNNNNNN NNNNNNNNNN GCCTCTGCCT CTGANCTATT CNNGAAGTAG TGAGGAGGCT
               61 TTTTTGGAGG CCTAGGCTTT TGCAAAAAGC TCCCGGGAGC TTGTATATCC ATTTTCGGAT
              121 CTGATCAAGA GACAGGATGA GGATCGTTTC GCATGATTGA ACAAGATGGA TTGCACGCAG
              181 GTTCTCCGGC CGCTTGGGTG GAGAGGCTAT TCGGCTATGA CTGGGCACAA CAGACAATCG
              241 GCTGCTCTGA TGCCGCCGTG TTCCGGCTGT CAGCGCAGGG GCGCCCGGTT CTTTTTGTCA
              301 AGACCGACCT GTCCGGTGCC CTGAATGAAC TGCAGGACGA GGCAGCGCGG CTATCGTGGC
              361 TGGCCACGAC GGGCGTTCCT TGCGCAGCTG TGCTCGACGT TGTCACTGAA GCGGGAAGGG
              421 ACTGGCTGCT ATTGGGCGAA GTGCCGGGGC AGGATCTCCT GTCATCTCAC CTTGCTCCTG
              481 CCGAGAAAGT ATCCATCATG GCTGATGCAA TGCGGCGGCT GCATACGCTT GATCCGGCTA
              541 CCTGCCCATT CGACCACCAA GCGAAACATC GCATCGAGCG AGCACGTACT CGGATGGAAG
              601 CCGGTCTTGT CGATCAGGAT GATCTGGACG AAGAGCATCA GGGGCTCGCG CCAGCCGAAC
              661 TGTTCGCCAG GCTCAAGGCG CGCATGCCCG ACGGCGAGGA TCTCGTCGTG ACCCATGGCG
              721 ATGCCTGCTT GCCGAATATC ATGGTGGAAA ATGGCCGCTT TTCTGGATTC ATCGACTGTG
              781 GCCGGCTGGG TGTGGCGGAN CGCTATCANG ACATAGCGTT GGCTANCCGT GATATTGCTG
              841 AAGAGCTTGG CGGCGAANGG GCTGANCGCT TCCTCGNGCT TNNCGGNATC GCCGCNNCCG
              901 ANTCNCANCG CANCGNCNNN CTATCGCNTN CTNNNNNANN TNNNCTGANC GGNANTCNNG
            961 GGGNNCNNNA AATGACCNNN CNANNCGANN NCNNNNCNNG NCNNNNNNNN NN
            //

            Please visit Sequencing and PCR primers for primer information.


            References

            Original, user report and related articles

            original Shiratori, R., Glycolytic suppression dramatically changes the intracellular metabolic profile of multiple cancer cell lines in a mitochondrial metabolism-dependent manner. Sci. Rep. 9 (1): 18699 (2019). PMID 31822748.

            2023.01.16

            GNP_filter3_RDBDEP_html_221125.pl